Implantable Drug Delivery Devices

Implantable Drug Delivery Devices


Global Implantable Drug Delivery Devices Market to Reach US$41.2 Billion by 2030

The global market for Implantable Drug Delivery Devices estimated at US$27.2 Billion in the year 2023, is expected to reach US$41.2 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Spinal Implants segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.4 Billion While China is Forecast to Grow at 5.7% CAGR

The Implantable Drug Delivery Devices market in the U.S. is estimated at US$7.4 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Implantable Drug Delivery Devices Market - Key Trends & Drivers Summarized

What Are Implantable Drug Delivery Devices and Why Are They Transformative in Medicine?

Implantable drug delivery devices are specialized medical implants designed to provide targeted, controlled, and long-term drug release directly to specific areas within the body. These devices represent a transformative advancement in medicine, enabling treatment regimens that are both consistent and precise, particularly for chronic conditions like cancer, diabetes, and cardiovascular diseases. Unlike oral or injectable medications, which can vary in absorption rates, implantable devices ensure consistent drug dosing, improving treatment efficacy and reducing side effects. By bypassing the digestive system and delivering medication directly to target tissues, these devices offer a more effective solution for complex medical conditions, which is especially beneficial in oncology and endocrinology, where precise dosing is critical.

How Are Technological Advancements Shaping the Implantable Drug Delivery Market?

Advancements in biomaterials, microelectronics, and biotechnology have significantly enhanced the functionality, durability, and safety of implantable drug delivery devices. Modern devices are now made from biocompatible materials that resist degradation in the body, ensuring long-term efficacy and reducing the need for frequent replacements. Innovations such as wireless control and micro-pump technologies allow for programmable and adjustable drug release, enabling healthcare providers to tailor dosages based on a patient`s evolving condition. Furthermore, some devices now incorporate sensors and connectivity features that enable real-time monitoring of drug delivery, allowing for timely adjustments and better patient outcomes. These technological breakthroughs are broadening the scope of implantable devices, making them highly adaptable for treating a range of complex health conditions.

Why Are Implantable Drug Delivery Devices Becoming More Commonplace?

The increasing prevalence of chronic and lifestyle-related diseases, along with a growing aging population, has driven demand for more efficient, less invasive treatment options, making implantable drug delivery devices more commonplace in modern healthcare. Patients and healthcare providers are increasingly drawn to the convenience and reliability of these devices, which eliminate the need for frequent hospital visits and enhance patient adherence to prescribed regimens. Additionally, advances in minimally invasive surgical techniques have made the implantation process quicker and less painful, further encouraging adoption. This shift toward long-term, continuous medication delivery reflects a larger trend in healthcare focused on improving patient quality of life while ensuring effective disease management.

The Growth in the Implantable Drug Delivery Devices Market Is Driven by Several Factors

The growth in the implantable drug delivery devices market is driven by several factors, including rapid technological advancements, rising prevalence of chronic diseases, and an increased focus on personalized medicine. Innovations in biomaterials and miniaturization technologies have allowed for the development of durable, compact devices that provide reliable, controlled drug release, expanding the application of these devices to conditions like cancer, hormonal imbalances, and neurological disorders. Growing demand for targeted therapies and improved drug bioavailability has fueled the adoption of these devices, particularly as healthcare shifts toward patient-centered, precision treatment. Additionally, the expansion of healthcare infrastructure in emerging markets and increased healthcare spending globally are creating more opportunities for the adoption of these advanced devices, further supporting market growth.

SCOPE OF STUDY:

The report analyzes the Implantable Drug Delivery Devices market in terms of US$ Million by the following Application; Product Type; Technology; Type, and Geographic Regions/Countries:

Segments:
Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Other Applications); Product Type (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps, Other Product Types); Technology (Diffusion, Osmotic, Magnetic, Other Technologies); Type (Biodegradable, Non-biodegradable)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -
  • Abbott Laboratories
  • Allergan PLC
  • Bausch and Lomb, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Medtronic PLC
  • Merck & Co., Inc.
  • Teleflex, Inc.
  • Varian Medical Systems, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Implantable Drug Delivery Devices – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Demand for Targeted and Controlled Drug Release Mechanisms
Increased Adoption in Chronic Disease and Pain Management
Rising Focus on Biocompatible and Biodegradable Implantable Devices
Advancements in Micro- and Nano-technology for Precision Drug Delivery
Expansion of Implantable Drug Delivery in Oncology Treatments
Growth in Demand for Long-acting Implantable Devices in Diabetes Management
Surge in Use of Implantable Systems for Hormone Replacement Therapy
Demand for Minimally Invasive Implantable Drug Delivery Procedures
Integration of Smart Sensors for Real-time Drug Release Monitoring
Enhanced Patient Compliance with Sustained Release Drug Implants
Development of Refillable and Reusable Implantable Devices
Increasing Applications of Implantable Devices in Neurological Treatments
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Implantable Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Spinal Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Brachytherapy Seeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Bio-absorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Intraocular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Non-biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Diffusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 39: World Historic Review for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: World 16-Year Perspective for Osmotic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 42: World Historic Review for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: World 16-Year Perspective for Magnetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 44: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 45: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 47: World Recent Past, Current & Future Analysis for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 48: World Historic Review for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: World 16-Year Perspective for Contraception by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 50: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 51: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: World 16-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 53: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 54: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 56: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 57: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 59: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 60: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 62: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 63: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: World 16-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 65: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 66: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 68: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: USA Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: USA 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 71: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: USA Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: USA 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 74: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: USA Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: USA 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 77: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: USA Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: USA 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 80: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Canada Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Canada 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 83: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Canada Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Canada 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 86: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Canada Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Canada 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 89: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Canada Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Canada 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 92: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Japan Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Japan 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 95: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Japan Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Japan 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 98: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Japan Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Japan 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 101: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Japan Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Japan 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
CHINA
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 104: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: China Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: China 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 107: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: China Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: China 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 110: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: China Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: China 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 113: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: China Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: China 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 116: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 117: Europe Historic Review for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 119: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 122: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 125: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 128: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
FRANCE
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 131: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: France Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: France 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 134: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: France Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: France 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 137: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: France Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: France 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 140: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: France Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: France 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 143: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Germany Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Germany 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 146: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Germany Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Germany 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 149: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Germany Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Germany 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 152: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Germany Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Germany 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 155: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Italy Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Italy 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 158: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Italy Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Italy 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 161: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Italy Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Italy 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 164: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Italy Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Italy 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 167: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: UK Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: UK 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 170: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: UK Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: UK 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 173: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: UK Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: UK 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 176: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: UK Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: UK 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Rest of Europe 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Rest of Europe 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Europe 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of Europe 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Asia-Pacific 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Asia-Pacific 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Asia-Pacific 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Asia-Pacific 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 203: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Rest of World Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Rest of World 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 206: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Rest of World Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Rest of World 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 209: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Rest of World Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Rest of World 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 212: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Rest of World Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Rest of World 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings